10-QPeriod: Q1 FY2010

Trane Technologies plc Quarterly Report for Q1 Ended Mar 31, 2010

Filed May 7, 2010For Securities:TT

Summary

Trane Technologies plc (formerly Ingersoll-Rand plc) reported mixed financial results for the first quarter ended March 31, 2010. Net revenues saw a modest increase of 0.7% year-over-year, primarily driven by favorable currency impacts, though this was partially offset by lower volumes and a $14.7 million negative impact from the devaluation of the Venezuelan Bolivar. The company demonstrated improved operational efficiency, with cost of goods sold and selling and administrative expenses decreasing as a percentage of revenue, leading to a significant improvement in operating income to $133.5 million from $49.9 million in the prior year period. Despite the operational improvements, the company recorded a net loss attributable to Ingersoll-Rand plc of $1.4 million, compared to a loss of $26.7 million in the prior year. This was largely due to a substantial $54.0 million provision for income taxes, which included a $40.5 million non-cash charge related to new healthcare reform legislation. Discontinued operations also contributed a loss of $10.4 million. The company is actively managing its debt, with total debt decreasing and a focus on maintaining liquidity through its credit facilities and cash on hand.

Financial Highlights

47 data points
Beta

Revenue

$2.77B

27.4% Gross Margin

Net Income

$1.40M

0.1% Net Margin

Total Assets

$19.72B

Cash & Equivalents

$599.10M

Free Cash Flow

-$73.20M

Financial Statements
Beta
Revenue$2.77B
Cost of Revenue$2.01B
Gross Profit$756.70M
SG&A Expenses$617.20M
Operating Income$139.50M
Interest Expense$71.00M
Net Income$1.40M
Shares Outstanding (Basic)322.70M
Shares Outstanding (Diluted)336.60M

Key Highlights

  • 1Net revenues increased by 0.7% to $2,953.4 million, primarily due to favorable currency exchange rates.
  • 2Operating income significantly improved to $133.5 million from $49.9 million in the prior year, driven by productivity gains and cost efficiencies.
  • 3Net loss attributable to shareholders was $1.4 million, a substantial improvement from the $26.7 million loss in the first quarter of 2009.
  • 4The company recorded a $40.5 million non-cash charge in income tax expense related to the Patient Protection and Affordable Care Act.
  • 5Total debt decreased to $3,931.3 million from $4,096.6 million at the end of 2009.
  • 6Cash and cash equivalents decreased to $599.1 million from $876.7 million at the end of 2009.
  • 7Restructuring charges for the period were $10.4 million, indicating ongoing efforts to streamline operations.

Frequently Asked Questions

The primary driver for the 0.7% increase in net revenues was favorable currency exchange rates, which contributed 2.2%. However, this was partially offset by negative impacts from lower volumes, pricing, and the devaluation of the Venezuelan Bolivar.

Operating income saw a substantial improvement due to enhanced operational efficiencies. Cost of goods sold and selling and administrative expenses decreased as a percentage of revenue, driven by increased productivity, restructuring benefits from programs implemented in 2009, and acquisition synergies. These measures more than offset the impact of lower volumes and material costs.

The income tax provision for the quarter was $54.0 million, significantly higher than the prior year. This includes a $40.5 million non-cash charge related to the enactment of the Patient Protection and Affordable Care Act, which impacts the tax benefits associated with retiree drug subsidy programs.

The company has reduced its total debt to $3,931.3 million from $4,096.6 million at the end of 2009. This was achieved through debt repayments, including $262.1 million in payments of long-term debt during the quarter, partly offset by new commercial paper borrowings.